Journey Medical Corporati... (DERM)
NASDAQ: DERM
· Real-Time Price · USD
6.96
-0.30 (-4.13%)
At close: Aug 15, 2025, 3:59 PM
6.33
-9.11%
After-hours: Aug 15, 2025, 07:45 PM EDT
Journey Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.3M | -14.67M | -18.34M | 843K | -4.16M | -3.85M | -12.35M | -39.22M | -38.39M | -29.63M | -40.74M | -41.3M | -45.64M | -43.99M | -19.74M | -9.07M | 3.25M |
Depreciation & Amortization | 3.77M | 3.52M | 3.35M | 3.35M | 3.6M | 3.85M | 4.26M | 4.47M | 4.42M | 4.37M | 3.63M | 3.27M | 2.99M | 2.56M | 2.43M | 2.13M | 1.74M |
Stock-Based Compensation | 6.01M | 6.1M | 5.25M | 4.17M | 3.37M | 2.61M | 3.52M | 4.4M | 4.3M | 4.42M | 5.41M | 3.98M | 3.22M | 2.47M | 63K | 87K | 276K |
Other Working Capital | 3.38M | -1.98M | -121K | -7.44M | 3.27M | -6.04M | -8.01M | -3.81M | -16.77M | -4.53M | -6.51M | -16.75M | 4.46M | 686K | 15.61M | 23.05M | 5.8M |
Other Non-Cash Items | -74K | -302K | 19.33M | 19.93M | 20.08M | 20.25M | 1.27M | 1.26M | 1.16M | 1.06M | 4.9M | 15.75M | 20.36M | 20.51M | 16.44M | 5.53M | 1.79M |
Deferred Income Tax | n/a | n/a | -19.48M | -19.56M | -15.97M | -15.97M | 3.51M | 3.59M | n/a | n/a | 8.27M | 4.91M | 1.5M | 1.57M | -7.99M | -4.61M | -1.2M |
Change in Working Capital | -8.34M | -3.77M | -17.99M | -16.7M | -5.74M | -1.66M | 17.71M | 17.35M | 13.08M | 6.19M | 5.57M | 14.87M | 14.91M | 14.71M | 14.88M | 3.84M | 56K |
Operating Cash Flow | -6.94M | -9.13M | -27.87M | -7.97M | 1.18M | 5.24M | 17.92M | -8.11M | -15.37M | -13.53M | -12.9M | 1.48M | -2.66M | -2.18M | 6.08M | -2.09M | 5.92M |
Capital Expenditures | n/a | n/a | 5M | 5M | 5M | n/a | -25M | -25M | -25M | -40M | -21.2M | -30M | -30M | -10M | -9M | -200K | -200K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -15M | -15M | n/a | n/a | n/a | -5M | 15M | 15M | 15M | n/a | -21.2M | -30M | -30M | -10M | -9M | -1.2M | -1.2M |
Investing Cash Flow | -15M | -15M | 5M | 5M | 5M | n/a | -25M | -25M | -25M | -40M | -21.2M | -30M | -30M | -10M | -9M | -1.2M | -1.2M |
Debt Repayment | -625K | n/a | 19.32M | 9M | -9M | -8.95M | -25.95M | -10.95M | 2.05M | 13.95M | 16.76M | 19.8M | 18.8M | 5.05M | 3.74M | -3.3M | -2.3M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -371K | -1.92M | -1.92M | -1.92M | -1.55M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -365K | -365K | -365K | -365K | n/a | n/a |
Other Financial Acitivies | 16.81M | 16.96M | -131K | -318K | -406K | -559K | 2.86M | 2.89M | 3.09M | 2.5M | 30.54M | 30.41M | 30.12M | 29.36M | -1.61M | -1.51M | -1.33M |
Financial Cash Flow | 18.95M | 16.99M | 25.49M | 14.81M | -3.31M | -4.89M | -23.07M | -8.06M | 5.14M | 16.46M | 47.31M | 54.49M | 54.99M | 53.02M | 20.73M | 9.52M | 8.9M |
Net Cash Flow | -2.99M | -7.13M | -2.29M | 6.93M | -2.04M | -4.56M | -10.14M | -21.16M | -15.23M | -17.08M | 13.2M | 25.97M | 22.33M | 40.84M | 17.81M | 6.23M | 13.62M |
Free Cash Flow | -6.94M | -9.13M | -22.78M | -2.88M | 6.27M | 5.33M | -7.08M | -33.1M | -40.37M | -53.53M | -34.1M | -28.52M | -32.66M | -12.18M | -2.92M | -2.29M | 5.72M |